Dimethylglycine, a glycine derivative, is a well-known inhibitor of betaine-homocysteine methyltransferase and contributes to elevated plasma homocysteine concentrations in patients [21] and animals [22] with renal failure. The gene discussed is BHMT; the disease is kidney failure.